CD14 and renal cell carcinoma: We have previously shown that for glioblastoma and renal cell carcinoma patients, an increase in peripheral blood CD14+HLA-DRlo/neg monocytes was associated with increased infiltration of CD14+ cells within the tumor [16, 23].